A Review of Candida auris
Environmental Persistence and Evidence-Based Decontamination and Prevention Strategies
DOI:
https://doi.org/10.12775/QS.2026.49.67356Keywords
candida auris, hospital disinfection, decontamination, institutional guidelines, hospital fungal infectionsAbstract
Background. Candida auris is an emerging, multidrug-resistant fungal pathogen of
significant public health concern. Noted for its environmental persistence and high
transmissibility, it poses a substantial threat in healthcare settings, particularly in
intensive care units, driving the need for specific infection control protocols.
Aim. The aim of this study was a comparative analysis of environmental disinfection
methods used in the prevention and control of Candida auris in various countries and
healthcare facilities.
Material and methods. This review analyzed literature from 2016-2025, sourced
from databases such as PubMed, alongside public health guidelines and
epidemiological reports. A comparative analysis of the selected data was
conducted.
Results. Disinfection strategies against C. auris primarily recommend chlorine- and
hydrogen peroxide-based agents, with UV-C and vaporized hydrogen peroxide (VHP)
noted as supplementary measures. A comparative analysis revealed significant
international divergence, particularly regarding quaternary ammonium compounds
(QACs), which are largely restricted except in specific contexts like India. Overall
efficacy is highly variable and dependent on disinfectant selection, workflow, staff
training, and the consistency of protocol implementation.
Conclusions. Chlorine- and peroxide-based disinfectants are most effective against C.
auris, while QACs are discouraged despite their localized use. To counter variability
in international guidelines, a unified regulatory framework is recommended. Key
recommendations include standardizing procedures, enhancing staff training, and
maintaining strict surveillance. Further research, including hospital case studies, is
needed due to insufficient current data.
References
1. Association for Professionals in Infection Control and Epidemiology (2025). About
Candida auris, https://apic.org/candida-auris
2. Bandara, N. & Samaranayake, L. P. (2022). Emerging strategies for environmental
decontamination of the nosocomial fungal pathogen Candida auris. Journal of Medical
Microbiology, 71(6), 1-10, https://doi.org/10.1099/jmm.0.001548
3. Barbian, H. J., Liel, L., Kittner, A., Harrington, A., Carson, J., Frias, M., Slade, D. H.,
Kim, D. Y., Black, S., Parada, J. P. & Hayden, M. K. (2025). Candida auris Outbreak
and Epidemiologic Response in Burn Intensive Care Unit, Illinois, USA, 2021–2023.
Emerging Infectious Diseases, 31(3)
4. Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit (2024). Merkblatt
Candida auris für Krankenhäuser.
5. Bednarowska-Michaiel, Z. (2015). Desk research - wykorzystanie potencjału danych
zastanych w prowadzeniu badań marketingowych i badań społecznych. Marketing i
Rynek, 7, 18-26
6. CDC (2019). Drug-resistant Candida Auris. Antibiotic Resistance Threats Report
7. CDC (2024). Infection Control Guidance: Candida auris, https://www.cdc.gov/
candida-auris/hcp/infection-control/index.html
8. Czajkowski, J. (2025). Zastosowanie technologii biodekontaminacji VHP (gazowy
nadtlenek wodoru) na rynku farmaceutycznym, w przemyśle oraz sektorze naukowo-
badawczym. Steris
9. European Centre for Disease Prevention and Control (2016). Candida auris in
healthcare settings – Europe. Stockholm
10. Florida Department of Health (2025). Candida auris Mini Education Facilitator Guide.
11. Grondalska, D. & Kmieciak, W. (2017). Candida auris - nowy patogen grzybiczy,
Postępy Mikrobiologii - Advancements of Microbiology, 56(3), 282-288, https://
doi.org/10.21307/PM-2017.56.3.282
12. Indian Council of Medical Research (2017). Candida auris in healthcare settings –
India.
13. Maslo, C., Plooy, M., & Coetzee, J. (2019). The efficacy of pulsed-xenon ultraviolet
light technology on Candida auris. BMC Infectious Diseases, 19(540), https://doi.org/
10.1186/s12879-019-4137-6
14. Mikołajczyk, A. (2018). Candida auris – nowe zagrożenie ze strony drobnoustrojów.
Aktualności Narodowego Programu Ochrony Antybiotyków, 2, 1-5.
15. Omardien, S. & Teska, P. (2024). Skin and hard surface disinfection against Candida
auris – What we know today. Front. Med, 11, https://doi.org/10.3389/
fmed.2024.1312929
16. Schelenz, S., Hagen, F., Rhodes, J. L., Abdolrasouli, A., Chowdhary, A., Hall, A.,
Ryan, L., Shackleton, J., Trimlett, R., Meis, J. F., Armstrong-James, D., & Fisher, M.
C. (2016). First hospital outbreak of the globally emerging Candida auris in a
European hospital. Antimicrobial Resistance & Infection Control, 5(35), https://
doi.org/10.1186/s13756-016-0132-5
17. Skrzypiec, P. (2025). Elementy szpitalnej strategii higieniczno-dezynfekcyjnej.
Obszar: ręce. Wrocław: Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu
18. UK Health Security Agency (2025). Infection prevention and control (IPC), https://
www.gov.uk/government/publications/candida-auris-laboratory-investigation-
management-and-infection-prevention-and-control/infection-prev
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Marta Krzyzaniak, Izabela Brynczka, Klaudia Martyna Patrzykąt, Zofia Gorzoch- Burduk, Julia Puzio, Paula Marcinkowska, Michał Jezierski, Kinga Popielarska, Ewelina Nowicka, Kamila Wróblewska

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 85
Number of citations: 0